Symposia - Industry Supported

Industry Supported Symposia at the Annual Meeting

Register now for the CPNP Annual Meeting where these Industry Supported Symposia will be featured!

  • Attendance at symposia is included within the CPNP full and daily registration fee options; no additional registration fees are required.
  • Your Annual Meeting registration does not guarantee you space in an industry symposium. Registration will be accepted on a first-come, first-served basis on-site; therefore, pre-registration is not required. Doors will open at start time noted in agenda for each symposium.
  • ACPE credit is arranged through the individual symposium providers as described within the symposium descriptions. When attending each symposium, please follow the provider's specific instructions regarding ACPE credit to ensure you receive credit accordingly.
  • All symposia will be help in Texas Ballroom D/E at the Grand Hyatt San Antonio.

Monday, April 19, 2010: 11:15 AM – 1:15 PM

Download the 2010 CPNP Annual Meeting Industry Symposia Brochure

From Rating Scales to Reality: Translating Clinical Trial Data into Meaningful Clinical Outcomes in Schizophrenia

Expert faculty will conduct live, interactive presentations to help participants resolve issues surrounding the difficulty of translating findings from clinical trial study methods into daily practice and management of schizophrenia, with particular focus on rating scales. Faculty will review practical insights into answering questions like:   

  • “Which rating scales are best for screening, assessment, and maintenance?”
  • “Who is the best practitioner to complete the scale?”
  • “How frequently should the scale be used?”
  • “How is the score interpreted?”
  • “Is there a core group of symptoms that should be assessed?”
  • “How do we translate clinical trial data to clinical practice?”

An interactive approach will be used to improve the learning experience. Audience participation will be encouraged by incorporating audience response keypads and interactive questioning.

Faculty

Deanna L. Kelly, PharmD, BCPP (Activity Chair)
Associate Professor of Psychiatry
Director and Chief, Treatment Research Program
Maryland Psychiatric Research Center
University of Maryland School of Medicine
Baltimore, MD

John M. Kane, MD
Chief of Staff and Chairman
Deptartment of Psychiatry
The Zucker Hillside Hospital
Dr. E. Richard Feinberg Chair in Schizophrenia Research
Professor of Psychiatry, Neurology, and Neuroscience
Albert Einstein College of Medicine
Bronx, NY

Additional Information

Monday, April 19, 2010: 3:45-5:30 PM

Download the 2010 CPNP Annual Meeting Industry Symposia Brochure

Long-Acting Injectable Antipsychotics:  A to Z

This engaging, interactive educational session will look back on the history of long-acting injectable antipsychotic agents used in the treatment of schizophrenia. We will review relevant pearls to provide a framework for younger clinicians who were not present for the evolution of this class and may not be aware of historical issues with this formulation, including pharmacokinetic differences, administration issues, and potential barriers to use. Expert speakers will provide a detailed outline of all long-acting injectables currently FDA-approved for schizophrenia and examine how they may optimally be used to improve adherence and patient care in a case-based approach. Pros/cons for each agent will be discussed, as well as practical pharmacokinetics, dosing and switching strategies, and administration pearls that pharmacists may use to assist nursing staff in the administration of these agents.

Faculty

Jeffrey R. Bishop, PharmD, BCPP (Activity Chair)
Assistant Professor, Department of Pharmacy and Psychiatry
University of Illinois at Chicago
Chicago, Illinois

Matthew Byerly, MD
Associate Professor of Psychatiry
University of Texas Southwestern Medical Center at Dallas
Dallas, TX

John M. Kane, MD
Chief of Staff and Chairman
Deptartment of Psychiatry
The Zucker Hillside Hospital
Dr. E. Richard Feinberg Chair in Schizophrenia Research
Professor of Psychiatry, Neurology, and Neuroscience
Albert Einstein College of Medicine
Bronx, NY

Eric C. Kutscher, PharmD, BCPP
Associate Professor of Pharmacy Practice
South Dakota State University College of Pharmacy
Clinical Pharmacy Specialist, Psychiatry
Avera Behavioral Health Center
Sioux Falls, SD

Additional Information

Tuesday, April 20, 2010: 12:00 – 2:00 PM

Download the 2010 CPNP Annual Meeting Industry Symposia Brochure

When Antidepressants Fall Short: Augmentation Strategies in Major Depressive Disorder

Expert faculty will review diagnosis and treatment of complicated Major Depressive Disorder (MDD) when conventional treatments fail. An interactive approach will be used to improve the learning experience. Audience participation will be encouraged by incorporating audience response keypads to respond to clinical cases. Participants will use information obtained during the symposium to enhance patient care by translating this information into clinical practice, teaching of residents/physicians, and in making more appropriate drug selection decisions for formularies and clinical treatment algorithms.

Faculty

Leigh Anne Nelson, PharmD, BCPP (Activity Chair)
Assistant Professor
School of Pharmacy
Division of Pharmacy Practice and Administration
University of Missouri-Kansas City
Kansas City, MO

Roger S. McIntyre, MD, FRCPC
Associate Professor of Psychiatry and Pharmacology
University of Toronto   
Head, Mood Disorders Psychopharmacology Unit 
University Health Network
Toronto, Ontario, CA

J. Craig Nelson, MD
Professor of Psychiatry
University of California, San Francisco
San Francisco, CA

Additional Information